National Jewish Health at ACT 2026

Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website

National Jewish Health takes part in 1 session at ACT 2026 in San Antonio, and exhibits at Booth 205. Its program centres on immune safety testing, with a performance check of MicroVue, a multiplex antibody-based assay (ELISA) that measures the complement proteins Bb, C3a and C5a in human plasma.

OrganizationACT 2026 Attendance
nationaljewish.org
Specialist testing laboratories
Denver respiratory hospital whose accredited diagnostic labs run complement, cytokine and immunology testing for nonclinical and clinical studies.
Booth
Exhibiting at Booth 205
Mon, Nov 169:30am–6:30pmTue, Nov 178:00am–4:30pm
Poster
Mon Nov 16
5:00pm–6:30pm
Performance Evaluation of MicroVue Multiplex ELISA for Quantification of Bb, C3a, and C5a in Human Plasma (P429)
Nelson Exhibit Ballroom · Poster P429
Immunotoxicology · Bioanalysis and biomarkers

Explore the full ACT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full ACT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from National Jewish Health

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction